Future perspectives on neuroendocrine tumors

被引：7

作者：

Castellano, Daniel ^{[1
]}

Salazar, Ramon ^{[3
]}

Raymond, Eric ^{[2
]}

机构：

[1] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid 28041, Spain

[2] Beaujon Univ Hosp, Dept Med Oncol, Clichy, France

[3] ICO Duran i Reynals, Dept Med Oncol, Barcelona, Spain

来源：

CANCER AND METASTASIS REVIEWS | 2011年 / 30卷 / 01期

关键词：

Gastroenteropancreatic neuroendocrine tumors; Genetics; Molecular markers; Diagnosis; Staging; Treatment; PROMID trial; Angiogenesis; RADIANT trials; ENDOCRINE PANCREATIC TUMORS; CARCINOID-TUMORS; SOMATOSTATIN ANALOGS; MOLECULAR-GENETICS; GRADING SYSTEM; CELL; EXPRESSION; DIAGNOSIS; MIDGUT; MODEL;

D O I：

10.1007/s10555-011-9294-z

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

In the last 30 years the incidence and prevalence of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has increased substantially. This could be partly due to improvements in diagnostic imaging, which lead to the incidental diagnosis of asymptomatic cases. However, despite these improvements, patients typically experience long delays before they are diagnosed. In this review, we discuss both the limitations and advances in our understanding of the pathogenesis, molecular and cellular biology, diagnosis, classification, staging, and treatment of GEP-NETs in order to identify which factors could be contributing to the delay in diagnosis and timely treatment of these patients. Within this context, the results from the most relevant clinical trials the available targeted therapies for the treatment of GEP-NETs, such as the "RAD001 in Advanced Neuroendocrine Tumors," will be discussed.

引用

页码：35 / 40

页数：6

共 45 条

[1]

Intraoperative tumour detection using 111In-DTPA-D-Phe1-octreotide and a scintillation detector [J].

Benjegård, SA ;

Forssell-Aronsson, E ;

Wängberg, B ;

Skånberg, J ;

Nilsson, O ;

Ahlman, H .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (10) :1456-1462

[2]

CASTELLANO D, 2010, 35 EUR SOC MED ONC 2

[3]

A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors [J].

Crabtree, JS ;

Scacheri, PC ;

Ward, JM ;

Garrett-Beal, L ;

Emmert-Buck, MR ;

Edgemon, KA ;

Lorang, D ;

Libutti, SK ;

Chandrasekharappa, SC ;

Marx, SJ ;

Spiegel, AM ;

Collins, FS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (03) :1118-1123

[4]

Ultrasonography of the pancreas. 4. Contrast-enhanced imaging [J].

D'Onofrio, M. ;

Zamboni, G. ;

Faccioli, N. ;

Capelli, P. ;

Pozzi Mucelli, R. .

ABDOMINAL IMAGING, 2007, 32 (02) :171-181

[5]

Varying Opinions on the Authenticity of a Human Midgut Carcinoid Cell Line - Letter [J].

Ellis, Lee M. ;

Samuel, Shaija ;

Sceusi, Eric .

CLINICAL CANCER RESEARCH, 2010, 16 (21) :5365-5366

[6]

Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas [J].

Fjallskog, Marie-Louise ;

Hessman, Ola ;

Eriksson, Barbro ;

Janson, Eva Tiensuu .

ACTA ONCOLOGICA, 2007, 46 (06) :741-746

[7]

Fjällskog MLH, 2003, CLIN CANCER RES, V9, P1469

[8]

Peptide receptor radionuclide therapy [J].

Forrer, Flavio ;

Valkema, Roelf ;

Kwekkeboom, Dik J. ;

de Jong, Marion ;

Krenning, Eric P. .

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (01) :111-129

[9]

ECL-cell derived gastric cancer in male cotton rats dosed with the H2-blocker loxtidine [J].

Fossmark, R ;

Martinsen, TC ;

Bakkelund, KE ;

Kawase, S ;

Waldum, HL .

CANCER RESEARCH, 2004, 64 (10) :3687-3693

[10]

Liver metastases arising from well-differentiated pancreatic endocrine neoplasms demonstrate increased VEGF-C expression [J].

Hansel, DE ;

Rahman, A ;

Hermans, J ;

de Krijger, RR ;

Ashfaq, R ;

Yeo, CJ ;

Cameron, JL ;

Maitra, A .

MODERN PATHOLOGY, 2003, 16 (07) :652-659

← 1 2 3 4 5 →